Closed · CDC-RFA-IP10-0070201SUPP12 · CFDA 93.185 · Discretionary
Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season
Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- August 10, 2012
- Close date
- -
- Expected awards
The verdict
Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season is a closed discretionary listing from Centers for Disease Control and Prevention that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.
- Varies
- award range
- Closed
- application status
- 93.185
- CFDA program
- 1,727
- other opportunities from Centers for Disease Control and Prevention
Archived opportunity record
Effectiveness of Empiric Antiviral Treatment… is closed (last close August 10, 2012). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed August 10, 2012
Est. Total Funding
$846,000
Instrument
Cooperative Agreement
Description
The purpose of the program is to continue the objectives of FOA IP10-007 to determine the effectiveness of empiric influenza antiviral therapy, in addition to empiric antibiotic therapy, for hospitalized CAP patients, and other patients with lower respiratory tract illness, during the periods when influenza viruses are circulating in the community. This program addresses the “Healthy People 2020” focus area(s) of Immunization and Infectious Diseases.
Catch-all / unrestricted eligibility mark · CDC-RFA-IP10-0070201SUPP12
Grants.gov marks Effectiveness of Empiric Antiviral Treatment… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDC Procurement and Grants Office TIMS Phone 770-488-2700
More from Centers for Disease Control and Prevention
What to do next
Effectiveness of Empiric Antiviral Treatment… is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 93.185 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |